These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The change to non-CFC metered dose inhalers. Rubinfeld A Aust Fam Physician; 1997 Dec; 26(12):1412-4. PubMed ID: 9470296 [TBL] [Abstract][Full Text] [Related]
3. [Progress of research on pressurized metered dose inhalers]. Zhou X Zhonghua Jie He He Hu Xi Za Zhi; 2013 Mar; 36(3):213-5. PubMed ID: 23856147 [No Abstract] [Full Text] [Related]
4. Preparing for a change in metered-dose inhalers. National Asthma Education and Prevention Program CFC Phaseout Working Group. Minn Med; 1998 Feb; 81(2):26-7. PubMed ID: 9505495 [No Abstract] [Full Text] [Related]
7. The president speaks: prevention is best: lessons from protecting the ozone layer. Woodcock A Thorax; 2012 Dec; 67(12):1028-31. PubMed ID: 23019254 [TBL] [Abstract][Full Text] [Related]
8. The CFC to HFA transition and its impact on pulmonary drug development. Leach CL Respir Care; 2005 Sep; 50(9):1201-8. PubMed ID: 16122403 [TBL] [Abstract][Full Text] [Related]
9. Economics of "essential use exemptions" for metered-dose inhalers under the Montreal Protocol. DeCanio SJ; Norman CS J Environ Manage; 2007 Oct; 85(1):1-8. PubMed ID: 16982135 [TBL] [Abstract][Full Text] [Related]
10. Switching to CFC-free beclometasone for asthma. Drug Ther Bull; 2008 Jun; 46(6):46-8. PubMed ID: 18525059 [TBL] [Abstract][Full Text] [Related]
12. Low incidence of paradoxical bronchoconstriction with bronchodilator drugs administered by Respimat Soft Mist inhaler: results of phase II single-dose crossover studies. Koehler D; Pavia D; Dewberry H; Hodder R Respiration; 2004; 71(5):469-76. PubMed ID: 15467324 [TBL] [Abstract][Full Text] [Related]
13. Overcoming dose-counting mechanisms on metered-dose inhalers for urgent treatment in the operating room. Templeton LB; Galyon SW; Smith TE Anesth Analg; 2009 Nov; 109(5):1709-10. PubMed ID: 19843820 [No Abstract] [Full Text] [Related]
14. An anesthetic in use with bronchodilator inhaler: a fact less known. Kummar P; Korula G; Ninan S; Karthikeyan C Ann Card Anaesth; 2010; 13(1):77-8. PubMed ID: 20075547 [No Abstract] [Full Text] [Related]
15. Final count down to hfa albuterol inhalers: are we ready as yet? Butt AT; Kamat D; Pansare M Clin Pediatr (Phila); 2009 Mar; 48(2):131-4. PubMed ID: 19015282 [No Abstract] [Full Text] [Related]
16. A switch to eco-friendly inhalers. Johns Hopkins Med Lett Health After 50; 2009 Mar; 21(1):2. PubMed ID: 19370797 [No Abstract] [Full Text] [Related]
17. Cumulative dose response study comparing HFA-134a albuterol sulfate and conventional CFC albuterol in patients with asthma. Ramsdell JW; Colice GL; Ekholm BP; Klinger NM Ann Allergy Asthma Immunol; 1998 Dec; 81(6):593-9. PubMed ID: 9892032 [TBL] [Abstract][Full Text] [Related]
18. A review of the development of Respimat Soft Mist Inhaler. Dalby R; Spallek M; Voshaar T Int J Pharm; 2004 Sep; 283(1-2):1-9. PubMed ID: 15363496 [TBL] [Abstract][Full Text] [Related]
19. Albuterol HFA is as effective as albuterol CFC in preventing exercise-induced bronchoconstriction. Hawksworth RJ; Sykes AP; Faris M; Mant T; Lee TH Ann Allergy Asthma Immunol; 2002 May; 88(5):473-7. PubMed ID: 12027068 [TBL] [Abstract][Full Text] [Related]
20. Possible replacements for CFC-propelled metered-dose inhalers. Dalby RN Med Device Technol; 1991 May; 2(4):21-5. PubMed ID: 10149436 [No Abstract] [Full Text] [Related] [Next] [New Search]